CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 3.3

ph-index = 10

Forward Citations = 270(Granted Patents)

Location History:

San Diego, CA (US) (1989)
Del Mar, CA (US) (1988 - 2021)

Company Filing History:

29 out of 15,471

University of California

patents

1 out of 134

Ligand Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 1988-2021

Loading Chart...

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10912764 - Salinosporamides and methods of use thereof (2021-02-09),

2. 10314818 - Salinosporamides and methods of use thereof (2019-06-11),

3. 9713607 - Salinosporamides and methods of use thereof (2017-07-25),

4. 9481662 - Seriniquinones, melanoma-specific anticancer agents (2016-11-01),

5. 9078881 - Salinosporamides and methods of use thereof (2015-07-14),

6. 8637565 - Salinosporamides and methods for use thereof (2014-01-28),

7. 8222289 - Salinosporamides and methods for use thereof (2012-07-17),

8. 8217072 - Salinosporamides and methods for use thereof (2012-07-10),

9. 8133902 - Ammosamides as anticancer agents (2012-03-13),

10. 7928138 - Marine actinomycete taxon for drug and fermentation product discovery (2011-04-19),

11. 7879576 - Marine actinomycete taxon for drug and fermentation product discovery (2011-02-01),

12. 7635712 - Salinosporamides and methods for use thereof (2009-12-22),

13. 7521414 - Polyol macrolide antitumor-antibiotics from the marine actinomycete strain CNQ140 (2009-04-21),

14. 7179834 - Salinosporamides and methods for use thereof (2007-02-20),

15. 7176233 - Salinosporamides and methods for use thereof (2007-02-13),

Certainly! Here is an article about inventor William H Fenical:

Title: William H Fenical: A Trailblazer in Innovation

Introduction:

William H Fenical, a renowned inventor based in Del Mar, CA, is a visionary in the world of inventions. With a total of 29 patents under his belt, his contributions have greatly impacted the field of marine actinomycetes and their applications in medicine.

Latest Patents:

Among his latest patented inventions are the salinosporamides and their methods of use. These compounds, derived from marine actinomycete strains CNB392 and CNB476, have proven to be effective inhibitors of hyperproliferative mammalian cells. They exhibit low molecular weight, high pharmaceutical potency, and selectivity for cancer cells, making them promising candidates for treating neoplastic disorders.

Career Highlights:

William H Fenical has made significant strides in his career, with notable contributions at the University of California and Ligand Pharmaceuticals, Inc. His expertise in marine microbiology and pharmaceuticals has led to groundbreaking discoveries in the development of novel therapeutics.

Collaborations:

Throughout his career, William H Fenical has collaborated with esteemed professionals in the field, including Paul R Jensen and Tracy Mincer. These collaborations have fostered a culture of innovation and knowledge exchange, leading to the successful development of cutting-edge technologies.

Conclusion:

In conclusion, William H Fenical's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors and researchers to push the boundaries of scientific discovery.

This text is generated by artificial intelligence and may not be accurate.